272 related articles for article (PubMed ID: 15272413)
1. Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel.
Joseph S; Jones FM; Walter K; Fulford AJ; Kimani G; Mwatha JK; Kamau T; Kariuki HC; Kazibwe F; Tukahebwa E; Kabatereine NB; Ouma JH; Vennervald BJ; Dunne DW
J Infect Dis; 2004 Aug; 190(4):835-42. PubMed ID: 15272413
[TBL] [Abstract][Full Text] [Related]
2. [Studies on human cytokine responses before and after praziquantel chemotherapy in an endemic area of schistosomiasis japonica].
Shen L; Wu HW; Zhang ZS; Weir R; Shao LJ; Xie ZW; Hu LS; Chen SZ; Su C; Zhang T; Taylor MG; Wu GL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(1):14-7. PubMed ID: 12567463
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults.
Brown M; Mawa PA; Joseph S; Bukusuba J; Watera C; Whitworth JA; Dunne DW; Elliott AM
J Infect Dis; 2005 May; 191(10):1648-57. PubMed ID: 15838791
[TBL] [Abstract][Full Text] [Related]
4. Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens.
Okano M; Satoskar AR; Nishizaki K; Abe M; Harn DA
J Immunol; 1999 Dec; 163(12):6712-7. PubMed ID: 10586068
[TBL] [Abstract][Full Text] [Related]
5. Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens.
Walter K; Fulford AJ; McBeath R; Joseph S; Jones FM; Kariuki HC; Mwatha JK; Kimani G; Kabatereine NB; Vennervald BJ; Ouma JH; Dunne DW
J Immunol; 2006 Oct; 177(8):5490-8. PubMed ID: 17015735
[TBL] [Abstract][Full Text] [Related]
6. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
[TBL] [Abstract][Full Text] [Related]
7. Carriage of DRB1*13 is associated with increased posttreatment IgE levels against Schistosoma mansoni antigens and lower long-term reinfection levels.
Booth M; Shaw MA; Carpenter D; Joseph S; Kabatereine NB; Kariuki HC; Mwatha JK; Jones FM; Vennervald BJ; Ouma JH; Dunne DW
J Immunol; 2006 Jun; 176(11):7112-8. PubMed ID: 16709874
[TBL] [Abstract][Full Text] [Related]
8. Naïve donor responses to Schistosoma mansoni soluble egg antigens.
Reis EA; Azevedo TM; McBride AJ; Harn DA; Reis MG
Scand J Immunol; 2007 Dec; 66(6):662-70. PubMed ID: 18021364
[TBL] [Abstract][Full Text] [Related]
9. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L
Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515
[TBL] [Abstract][Full Text] [Related]
10. Human schistosomiasis mansoni: intensity of infection differentially affects the production of interleukin-10, interferon-gamma and interleukin-13 by soluble egg antigen or adult worm antigen stimulated cultures.
Silveira AM; Gazzinelli G; Alves-Oliveira LF; Bethony J; Gazzinelli A; Carvalho-Queiroz C; Alvarez MC; Lima-Silva FC; Prata A; LoVerde PT; Correa-Oliveira R
Trans R Soc Trop Med Hyg; 2004 Sep; 98(9):514-9. PubMed ID: 15251399
[TBL] [Abstract][Full Text] [Related]
11. Cytokine production in acute versus chronic human Schistosomiasis mansoni: the cross-regulatory role of interferon-gamma and interleukin-10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens.
Montenegro SM; Miranda P; Mahanty S; Abath FG; Teixeira KM; Coutinho EM; Brinkman J; Gonçalves I; Domingues LA; Domingues AL; Sher A; Wynn TA
J Infect Dis; 1999 Jun; 179(6):1502-14. PubMed ID: 10228073
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel.
Reimert CM; Tukahebwa EM; Kabatereine NB; Dunne DW; Vennervald BJ
Acta Trop; 2008 Mar; 105(3):253-9. PubMed ID: 18177822
[TBL] [Abstract][Full Text] [Related]
13. Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection.
Joseph S; Jones FM; Laidlaw ME; Mohamed G; Mawa PA; Namujju PB; Kizza M; Watera C; Whitworth JA; Dunne DW; Elliott AM
J Infect Dis; 2004 Aug; 190(3):613-8. PubMed ID: 15243939
[TBL] [Abstract][Full Text] [Related]
14. Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection.
Mwinzi PN; Karanja DM; Colley DG; Orago AS; Secor WE
J Infect Dis; 2001 Aug; 184(4):488-96. PubMed ID: 11471107
[TBL] [Abstract][Full Text] [Related]
15. Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens.
Hayashi N; Matsui K; Tsutsui H; Osada Y; Mohamed RT; Nakano H; Kashiwamura S; Hyodo Y; Takeda K; Akira S; Hada T; Higashino K; Kojima S; Nakanishi K
J Immunol; 1999 Dec; 163(12):6702-11. PubMed ID: 10586067
[TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
[TBL] [Abstract][Full Text] [Related]
17. Are the cellular immune responses of children and adults with Schistosoma mansoni infection intrinsically different? Cytokines produced ex vivo in response to antigens and mitogens.
Scott JT; Vereecken K; Diakhaté MM; Vanagt T; Sambou V; Diop M; Ly A; Vercruysse J; Gryseels B; Kestens L
Parasite Immunol; 2004 Jan; 26(1):29-36. PubMed ID: 15198643
[TBL] [Abstract][Full Text] [Related]
18. Impact of interleukin-1 and interleukin-6 in murine primary schistosomiasis.
El Ridi R; Wagih A; Salem R; Mahana N; El Demellawy M; Tallima H
Int Immunopharmacol; 2006 Jul; 6(7):1100-8. PubMed ID: 16714213
[TBL] [Abstract][Full Text] [Related]
19. Posttreatment changes in cytokines induced by Schistosoma mansoni egg and worm antigens: dissociation of immunity- and morbidity-associated type 2 responses.
Wilson S; Jones FM; Kenty LC; Mwatha JK; Kimani G; Kariuki HC; Dunne DW
J Infect Dis; 2014 Jun; 209(11):1792-800. PubMed ID: 24357629
[TBL] [Abstract][Full Text] [Related]
20. SCHISTOSOMA MANSONI INFECTION AND THE ASSOCIATED ANTIBODY IMMUNE RESPONSE AMONGST RESIDENTS OF KIGUNGU ENTEBBE, UGANDA.
Odongo-Aginya EI; Wilson RA; Kyabayinze D; Sempewo H; Oliveira RC; Kironde F
East Afr Med J; 2012 Apr; 89(4):111-20. PubMed ID: 26856035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
